跳至主要内容
临床试验/NCT07452289
NCT07452289已完成不适用

Arthrocentesis of Temporomandibular Joint Using Ozonated Water Alongside With Platelet Rich Plasma Injection in Management of Anterior Disc Displacement Without Reduction: (Randomized Controlled Clinical Trial)

Alexandria University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年7月2日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Change in maximum mouth opening

研究概览

简要总结

Background: The temporomandibular joint (TMJ) is a highly intricate and complex synovial joint found in the human body. When TMJ dysfunction occurs, it causes pain and difficulties in opening the mouth, significantly impacting the patient's quality of life. Internal derangements, characterized by the gradual displacement of the articular disc, stand out as the most prevalent intra-articular temporomandibular disorders. Temporomandibular joint arthrocentesis, a procedure utilizing different irrigating solutions, is acknowledged as an efficient therapy for managing internal derangements of the TMJ. Recently, ozone therapy and orthobiologics like Platelet rich plasma (PRP) have been attracting increasing attention worldwide due to their promising medical applications and diverse therapeutic benefits in management of joint dysfunctions.

Aim of this study: The aim of the study is to compare the effectiveness of temporomandibular joint arthrocentesis using ozonated water combined with platelet-rich plasma (PRP) injection versus ozonated water alone for treating Wilkes stages III and IV of anterior disc displacement in terms of pain score, maximum mouth opening, and range of motion. Additionally, the study aims to compare the impact of both treatments on the concentration of the proinflammatory cytokine interleukin-6 (IL-6) in the joint space.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Pain located in the affected TMJ, especially during opening.
  • Joint noises.
  • Limited mouth opening (less than 35 mm).
  • Impeded lateral movement toward the unaffected side.
  • Deflection toward the affected side in opening in cases of unilateral affection.
  • Patient who did not respond to conservative management.

排除标准

  • Patients receiving anticoagulation treatment or non-steroidal anti-inflammatory drugs within 48 hours preoperatively, corticosteroid injection at the treatment site within 1 month, or systemic use of corticosteroids within 2 weeks.
  • Patients suffering from any systemic inflammatory (degenerative) joint disease, and bleeding disorders such as coagulation disorders, platelet disorders, vascular disorders, and fibrinolytic defects.
  • Patients with overlying infection or cellulitis in preauricular region.
  • Patients with condylar pathology (hypoplasia, hyperplasia or tumor).
  • Patients with previous open TMJ surgery or previous joint fracture.
  • Patients with normal disc positions as seen by the MRI and the limitation is due to another extraarticular cause such as zygomatic arch fracture or elongated coronoid process.

研究组 & 干预措施

Study ozonated group

Experimental

干预措施: Ozonated water and PRP injection (Other)

Control group

Active Comparator

干预措施: Ozonated water (Other)

结局指标

主要结局

Change in maximum mouth opening

时间窗: up to 6 months

mouth opening will be measured as the maximal distance between the cutting edge of the maxillary and mandibular central incisors using a millimeter ruler in the superioinferior direction.

change in level of IL-6

时间窗: up to 6 months

synovial fluid samples will be collected to detect the level of IL-6

次要结局

  • change in lateral mandibular movement(up to 6 months)
  • change in protrusive movement(up to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验